"Only dull people are brilliant at breakfast" -Oscar Wilde |
"The liberal soul shall be made fat, and he that watereth, shall be watered also himself." -- Proverbs 11:25 |
owing to critics who contended it was putting profits before patients, Aetna said Wednesday that it had suspended — at least temporarily — a plan to stop paying for routine use of a powerful anesthetic in a procedure to screen for colon cancer.
The drug, propofol, provides quick and reliable sedation for patients who are undergoing a colonoscopy, an examination of the lower intestine with a flexible probe that provides the most thorough form of screening for colon cancer.
Because of federal regulatory recommendations and, in some cases, specific state regulations, propofol is often administered by an anesthesiologist instead of the doctor performing the colonoscopy.
Aetna said in December that it would stop paying for the use of propofol in routine cases as of April 1 because research showed the participation of an anesthesiologist added $300 to $1,000 to the screening costs without improving outcomes.
Aetna cited the practice as an example of unnecessary spending. It said doctors in many parts of the country who used propofol in just 10 percent of their cases were achieving the same results as those in areas like the New York City region, where close to 80 percent of patients received the drug.
Critics had said that restricting use of propofol would discourage patients from undergoing a colonoscopy. Cancers of the colon and rectum trail only lung and prostate cancer in cancer deaths among Americans, according to the Centers for Disease Control and Prevention, but survival rates are high when they are caught early.
Insurers have been split on whether to cover propofol for colonoscopies. Humana and WellPoint are among the large players that, like Aetna, have sought to curtail coverage while UnitedHealthcare, which has 26 million members, has advertised its intent to support propofol in all screenings. Medicare leaves the decision up to its local carriers, most of which have restrictive policies.
Some doctors maintain that propofol helps them by keeping patients calmer during screenings than the traditional cocktails they administered of sedatives like Versed and tranquilizers like Valium. And, because it wears off sooner, patients can go home more quickly.
Labels: health care, insurance industry
But they used Fentenynl and a nurse anesthetist when I had mine. Does that mean I got shortchanged?
I will never, ever have another colonoscopy.